“亚肝素化剂量”治疗肺心病心衰67例

来源 :临床医学 | 被引量 : 0次 | 上传用户:quhongliangs
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
我院自1984年以来,用“亚肝紊化剂量”的肝素治疗肺心病心衰67例,取得了较好的临床效果。并与随机分组不用肝素治疗的92例作对照。现总结报告如下: 临床资料一、病例选择:共159例,均系本院住院病人。其中男123例,女36例。年龄30~72岁。慢性肺心病心衰的诊断按“1987年全国第二次肺心病专业会议制定标准”,心功能不全按全国统一的标准(试行草案)判定,屏除有呼衰、肺脑、上消化道 Our hospital since 1984, with “sub-hepatic turbulent dose of heparin in the treatment of heart failure in 67 cases of pulmonary heart disease, and achieved good clinical results. And compared with 92 patients who were randomized without heparin treatment. Are summarized in the report are as follows: Clinical data First, the patient selection: A total of 159 cases were hospital patients in our hospital. There were 123 males and 36 females. Age 30 ~ 72 years old. Chronic pulmonary heart disease diagnosis According to ”1987 National Conference on the development of pulmonary heart disease professional standards", cardiac insufficiency according to the national standard (trial draft) to determine, except screen respiratory failure, pulmonary brain, upper gastrointestinal
其他文献
自体静脉是中小动脉重建的首选材料。自体静脉移植干动脉环境后发生创伤愈合性和适应性组织学改变,其演变趋势是新生血管内皮细胞的再增殖和内膜下层肌内膜细胞的游移、堆积
1.OverviewrnThe 2016 Intational Radiation Symposium,a joint venture between the IRC (Intational Radiation Commission) and IAMAS (Intational Association of Meteo
期刊
@@
从基因水平对血红蛋白H病进行研究,收获颇丰,成为当今分子生物学科内非常活跃的领域之一。该症起因于α珠蛋白结构基因缺失或功能障碍,导致α珠蛋白合成严重不足,使正常人HbA
学校要想搞好学生的思想道德建设,就必须要以学生为中心去开展工作,因为学生是我国未来发展建设的主要生力军.现阶段,随着我国综合国力的不断提升,社会对人才的要求越来越高,
The relationships between the tropical Indian Ocean basin(IOB)/dipole(IOD) mode of SST anomalies(SSTAs) and ENSO phase transition during the following year are
从绩效评价主体、评价指标、评价标准、计分权重及计分方法等层面的设计角度,论述了企业绩效考评机制的公平性,并提出提升绩效评价机制公平性的有关对策。 From the aspects
The summer Asian–Pacific Oscillation(APO) is a major teleconnection pattern that reflects the zonal thermal contrast between East Asia and the North Pacific in